<p>Subgroup classification for the 97 breast cancer patients (46 from patients who developed distant metastases within 5 years and 51 from patients who continued to be disease-free after a period of at least 5 years) using the SVM, RF, and DLDA composite models.</p
Background Data on distant disease-free interval (DDFI) and the localization of the first distant me...
Bone metastases (BM) are still the main cause of morbidity in cancer patients because of skeletal-re...
BackgroundBreast cancer (BC) survivors have an increased risk of developing second primary cancers (...
Among breast cancer patients who develop distant metastases, there is marked variability in the clin...
This study aimed to develop a model that fused multiple features (multi-feature fusion model) for pr...
<p>(A) Gene expression data of the 45 genes from 48 triple-negative patients in a heat map. Each row...
The aim of our retrospective study was to analyze patterns of subtype specific metastatic spread and...
The purpose of this research is to find out (1). Characteristics of breast cancer patients (2). Type...
The purpose of this research is to find out (1). Characteristics of breast cancer patients (2). Type...
IntroductionThe present study was designed to describe tumour features and treatments for patients w...
Little is known about time trends in metastases in the patients treated in routine health care facil...
We employed a semi-Markov multistate model for the simultaneous analysis of various endpoints descri...
<p>Descriptive statistics for women diagnosed with metastatic breast cancer in 2005–2009, by occurre...
Introduction: Identifying the risk factors in the treatment of metastatic breast cancer patients is ...
Observational studies in metastatic breast cancer (MBC) show that long-term overall survival (OS) is...
Background Data on distant disease-free interval (DDFI) and the localization of the first distant me...
Bone metastases (BM) are still the main cause of morbidity in cancer patients because of skeletal-re...
BackgroundBreast cancer (BC) survivors have an increased risk of developing second primary cancers (...
Among breast cancer patients who develop distant metastases, there is marked variability in the clin...
This study aimed to develop a model that fused multiple features (multi-feature fusion model) for pr...
<p>(A) Gene expression data of the 45 genes from 48 triple-negative patients in a heat map. Each row...
The aim of our retrospective study was to analyze patterns of subtype specific metastatic spread and...
The purpose of this research is to find out (1). Characteristics of breast cancer patients (2). Type...
The purpose of this research is to find out (1). Characteristics of breast cancer patients (2). Type...
IntroductionThe present study was designed to describe tumour features and treatments for patients w...
Little is known about time trends in metastases in the patients treated in routine health care facil...
We employed a semi-Markov multistate model for the simultaneous analysis of various endpoints descri...
<p>Descriptive statistics for women diagnosed with metastatic breast cancer in 2005–2009, by occurre...
Introduction: Identifying the risk factors in the treatment of metastatic breast cancer patients is ...
Observational studies in metastatic breast cancer (MBC) show that long-term overall survival (OS) is...
Background Data on distant disease-free interval (DDFI) and the localization of the first distant me...
Bone metastases (BM) are still the main cause of morbidity in cancer patients because of skeletal-re...
BackgroundBreast cancer (BC) survivors have an increased risk of developing second primary cancers (...